Literature DB >> 21183450

Regression of lymphoma after withdrawal of infliximab alone in an infliximab/methotrexate-treated RA patient.

Neil Mo, Senthil Muthu, Margaret O'Sullivan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21183450     DOI: 10.1093/rheumatology/keq417

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  4 in total

1.  Safe use of infliximab for the treatment of severe perianal Crohn's disease after diagnosis and treatment of lymphoma.

Authors:  Carlos Bernardes; Pedro Russo; Diana Carvalho; Joana Saiote; Jaime Ramos
Journal:  Clin J Gastroenterol       Date:  2017-11-22

2.  Risk of malignancy in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under immunosuppressive therapy: a single-center experience.

Authors:  Marta Fantò; Mario Stefano Peragallo; Mario Pietrosanti; Roberta Di Rosa; Andrea Picchianti Diamanti; Simonetta Salemi; Raffaele D'Amelio
Journal:  Intern Emerg Med       Date:  2015-06-23       Impact factor: 3.397

3.  Characteristics and risk factors of lymphoproliferative disorders among patients with rheumatoid arthritis concurrently treated with methotrexate: a nested case-control study of the IORRA cohort.

Authors:  Yoko Shimizu; Ayako Nakajima; Eisuke Inoue; Kumi Shidara; Naoki Sugimoto; Yohei Seto; Eiichi Tanaka; Shigeki Momohara; Atsuo Taniguchi; Hisashi Yamanaka
Journal:  Clin Rheumatol       Date:  2017-04-28       Impact factor: 2.980

4.  Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab.

Authors:  Diana Carvalho; Pedro Russo; Carlos Bernardes; Joana Saiote; Gonçalo Ramos; Luís Mascarenhas; Nuno Borges; Jaime Ramos
Journal:  GE Port J Gastroenterol       Date:  2017-09-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.